Blog
RSS FeedPosted by Michael Wonder on 03 Jan 2025
New Zealand Pharmaceutical Schedule - 1 January 2025
1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 02 Jan 2025
New and expanded PBS listings for breast and prostate cancer
2 January 2025 - Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines ...
Posted by Michael Wonder on 01 Jan 2025
Schedule of Pharmaceutical Benefits - 1 January 2025
1 January 2025 - - The January 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in ...
Posted by Michael Wonder on 05 Dec 2024
PHARMAC funds more cancer and respiratory medicines for New Zealanders
6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...
Posted by Michael Wonder on 03 Dec 2024
New Zealand Pharmaceutical Schedule - 1 December 2024
1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Changes to the PBS listings for Opdualag and Vyxeos
1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...
Posted by Michael Wonder on 01 Dec 2024
Schedule of Pharmaceutical Benefits - 1 December 2024
1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Life changing endometriosis treatment now cheaper
1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...
Posted by Michael Wonder on 27 Nov 2024
Australians benefit from new and expanded medicines on the PBS
20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...
Posted by Michael Wonder on 12 Nov 2024
New heart medicine for 18,000 New Zealanders
12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...
Posted by Michael Wonder on 08 Nov 2024
Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer
8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...
Posted by Michael Wonder on 01 Nov 2024
Schedule of Pharmaceutical Benefits - 1 November 2024 update
1 November 2024 - The November 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Nov 2024
New Zealand Pharmaceutical Schedule - 1 November 2024
1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 11 Oct 2024
Roche Canada announces Columvi (glofitamab for injection) is publicly reimbursed in 7 provinces, including Quebec, Ontario, Manitoba, Saskatchewan, Nova Scotia and Newfoundland
9 October 2024 - Columvi is now publicly covered in 7 provinces, which equates to approximately 74% of the total Canadian ...
Posted by Michael Wonder on 10 Oct 2024
PHARMAC improves access to three cancer medicines
10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...